Peminic’s Board of Directors is comprised of investor representatives and industry experienced executives providing key business, clinical, financial and strategic contributions and oversight.

Dr. Jennifer Daley
Chief Medical Officer, Partners Community Healthcare Inc.(http://www.partners.org/about/about_pchi.html)

Dr. Jennifer Daley is the Chief Medical Officer of Partners Community Healthcare Inc., the physician contracting organization for the six thousand physicians employed and/or affiliated with Partners Healthcare System in Boston Massachusetts.   Jennifer is a nationally recognized physician executive with expertise in patient safety, quality, service excellence, and clinical operational improvement.  She is distinguished in the health care industry for substantial clinical work redesign leading to quantifiable and sustainable improvements in patient outcomes and reduced costs of care.  She has led innovative quality improvement programs nationally in government (Department of Veterans Affairs), for-profit (Tenet Healthcare) and not-for-profit delivery systems (Partners Healthcare System, Beth Israel Deaconess Medical Center).  Jennifer received her Bachelor of Arts degree magna cum laude from Brown University and her medical degree at Tufts University School of Medicine.  She completed post-graduate training in internal medicine at the New England Medical Center in Boston and her general medicine fellowship at Harvard Medical School.   In 2007 she was named one of the top 25 women executives in healthcare by Modern Healthcare and was an inaugural recipient of the US Naval Academy-Harvard Business Review Ethical Leadership Award.

Kim Goh
Senior Managing Director, Hudson Venture Partners (www.hudsonptr.com)

Kim joined Hudson Ventures in 2000 as the Senior Managing Director. Prior to this, Kim had been a private investor and advisor to several start-ups.  From 1970 to 1997, Kim held a number of senior executive positions including Executive Vice President at Merck/Medco, a Director at Chemical Bank and the Head of their Retail Operations, Technology Head of Citibank’s Capital Market Group, the Global Equities Group and the International Private Bank. He was instrumental in acquiring, building and repositioning numerous companies.  Kim also served as the Representative for the Consumer Banking Association to the Electronic Benefits Transfer Task Force, Washington D.C.  Kim holds a B. A. degree from Southampton College, M. A. degree (Economics) from the New School University, Master of International Affairs degree from Columbia University, and Master of Science in Information Technology degree with distinction from Carnegie Mellon University. Kim is also a graduate of the Harvard University Advanced Management Program.

Mike Graham
Chief Executive Officer, Peminic Inc. (www.peminic.com)

See Mike’s bio in the Management section.

Charles E. Leonard III
Managing Director, Coady Diemar Partners (www.coadydiemar.com)

Chuck has over 35 years of operational, corporate development and corporate finance experience. Prior to joining CDP, Chuck spent three years as Chairman and Chief Executive Officer of Solucient LLC, a $100 million healthcare information services company. Chuck served as President of VNU's Marketing Information Services Group from 1990 to 2001 growing company revenues from $70 to $400 million. Chuck began his career with DuPont where he led the commercialization of Tyvek. Chuck has served on numerous Boards of Directors including Solucient, Allrecipes, Innovative Systems and Omnicom, as well as the National Science Foundation Advisory Board. Chuck holds BS and BA degrees from MIT and Middlebury College and an MBA from Wharton.

Fred Morris
Partner and Founder, Brook Venture Partners (www.brookventure.com)

Fred co-founded Brook Venture Partners in 1995.  Brook focuses on Medical Technology and Information Technology companies, having made investments in over 30 companies to date.  Prior to forming Brook, Fred held a variety of executive positions in the banking industry.  Fred founded and led the Specialized Lending Division of State Street Bank in Boston where he was a Senior Vice President and member of the Management Committee.  Additionally, Fred spent a number of years as an executive with First National City Bank, Citibank and U.S. Trust Company.  In addition to the Peminic Board, Fred sits on the Boards of HistoRx, Inc., Repromedix Corp., PointCare Technologies, Inc., Laser Projection Technologies, Inc. Atlas Watersystems, Inc., and the North Shore Technology Council (MA).  Fred holds a BA from Yale and earned his MBA from Harvard after serving as Lieutenant in the U.S. Navy.

Board Observers

Glen Lewy
Senior Managing Director, Hudson Venture Partners (www.hudsonptr.com)

Glen Joined Hudson Ventures in 2000 as a Senior Managing Director. Glen spent 25 years as an adviser to some of the world's largest and most prestigious corporations, having distinguished himself as both a lawyer and investment banker. Glen was a senior partner and member of the Management Committee of Wolfensohn & Co., when it was acquired by Bankers Trust in 1996. Following the acquisition, he served as a member of the Management Committee of Bankers Trust. Upon the acquisition of Bankers Trust by Deutsche Bank, Glen was named Global Head of the Mergers and Acquisitions and Corporate Advisory Group of Deutsche Bank and a member of the Board of Global Corporate and Institutions (the investment banking arm of Deutsche Bank).  Prior to joining Wolfensohn & Co., he had been a partner involved in the practice of corporate law, specializing in mergers and acquisitions, at the New York law firm of Debevoise & Plimpton.  Currently, Glen is a Board member of several technology-related companies and is the Chairman of the Anti-Defamation League National Commission. He is also a member of the Council of Foreign Relations, and sits on the Board of Trustees of the New York Historical Society and the SEED Foundation.  Glen holds a B.A. degree from Amherst College and a J.D. from the University of Chicago Law School.

Edward C. William III
Partner, Brook Venture Partners (www.brookventure.com)

Ned has spent a total of 20 years in private equity investing and has been responsible for dozens of rounds of financing in both early and expansion companies. Ned joined Brook Venture Partners in 1999 as a General Partner and a member of the fund's Investment Committee and is an active investor in and serves on several of Brook's portfolio company board of directors in both medical and information technology. Ned is a steering committee member of The Massachusetts Medical Device Development Center, which offers inventors and executives of the state's smaller medical device company’s easy, affordable, and coordinated access to world-class researchers and resources.  Ned is also an active member of the Executive Committee of the Northeast Regional Association of Small Business Investment Companies (NERASBIC).  Prior to joining Brook, Ned was a Managing Director at Saturn Asset Management, a Boston-based private equity firm.  Earlier in his career he was with Morgan Stanley in New York City where he was involved with over 25 Initial Public Offerings including the Netscape IPO as well as the spinout of Lucent Technologies from AT&T.